Medical Innovation Acceleration Act of 2023
Last action on Feb 6, 2025Referred to the Subcommittee on Health.
Take Action
Summary
Medical Innovation Acceleration Act of 2023
This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.
The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.
Lifecycle of the Bill
Referred to the Subcommittee on Health.
Feb 6, 2025
